Close

Analyst Ratings for Momenta Pharmaceuticals (MNTA) [Buys]

MNTA Rating Summary

  |   Expand Research on MNTA
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.8 / 10   Percentile Rank: 41%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/3/2020 TD Cowen Stacy Ku Upgrade Buy
(Hold)
40.00
(N/A)
29.49
(52.48)
77.96% Details
11/5/2018 Piper Sandler
» Updated 7/29/2020
Tyler Van Buren New Coverage Overweight
(N/A)
45.00
(N/A)
13.53
(52.48)
287.88% Details